{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T04:16:29Z","timestamp":1730261789431,"version":"3.28.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiologie"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s00117-024-01316-x","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T22:01:28Z","timestamp":1716588088000},"page":"559-567","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bildgebung von neuroendokrinen Tumoren des Pankreas","Imaging of pancreatic neuroendocrine tumors"],"prefix":"10.1007","volume":"64","author":[{"given":"Frank","family":"Berger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Ingenerf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph J","family":"Auernhammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens","family":"Cyran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricarda","family":"Ebner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Zacherl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Ricke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Schmid-Tannwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,24]]},"reference":[{"key":"1316_CR1","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.2967\/jnumed.115.162719","volume":"56","author":"V Ambrosini","year":"2015","unstructured":"Ambrosini\u00a0V, Campana\u00a0D, Polverari\u00a0G et\u00a0al (2015) Prognostic Value of 68Ga-DOTANOC PET\/CT SUVmax in Patients with Neuroendocrine Tumors of the Pancreas. J\u00a0Nucl Med 56:1843\u20131848","journal-title":"J Nucl Med"},{"key":"1316_CR2","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s00259-008-0769-2","volume":"35","author":"V Ambrosini","year":"2008","unstructured":"Ambrosini\u00a0V, Tomassetti\u00a0P, Castellucci\u00a0P et\u00a0al (2008) Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours. Eur J Nucl Med Mol Imaging 35:1431\u20131438","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1316_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.dld.2013.04.007","volume":"46","author":"F Attili","year":"2014","unstructured":"Attili\u00a0F, Capurso\u00a0G, Vanella\u00a0G et\u00a0al (2014) Diagnostic and therapeutic role of endoscopy in gastroenteropancreatic neuroendocrine neoplasms. Dig Liver Dis 46:9\u201317","journal-title":"Dig Liver Dis"},{"key":"1316_CR4","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S2213-8587(17)30401-1","volume":"6","author":"CJ Auernhammer","year":"2018","unstructured":"Auernhammer\u00a0CJ, Spitzweg\u00a0C, Angele\u00a0MK et\u00a0al (2018) Advanced neuroendocrine tumours of the small intestine and pancreas: clinical developments, controversies, and future strategies. Lancet Diabetes Endocrinol 6:404\u2013415","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1316_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.beem.2016.01.003","volume":"30","author":"T Baumann","year":"2016","unstructured":"Baumann\u00a0T, Rottenburger\u00a0C, Nicolas\u00a0G et\u00a0al (2016) Gastroenteropancreatic neuroendocrine tumours (GEP-NET)\u2014Imaging and staging. Best Pract Res Clin Endocrinol Metab 30:45\u201357","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1316_CR6","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1158\/1078-0432.CCR-09-1759","volume":"16","author":"T Binderup","year":"2010","unstructured":"Binderup\u00a0T, Knigge\u00a0U, Loft\u00a0A et\u00a0al (2010) 18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors. Clin Cancer Res 16:978\u2013985","journal-title":"Clin Cancer Res"},{"key":"1316_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/RLU.0000000000001431","volume":"42","author":"T Brabander","year":"2017","unstructured":"Brabander\u00a0T, Teunissen\u00a0J, Kwekkeboom\u00a0D (2017) Physiological Uptake in the Pancreatic Head on Somatostatin Receptor Scintigraphy Using [111In-DTPA]Octreotide: Incidence and Mechanism. Clin Nucl Med 42:15\u201319","journal-title":"Clin Nucl Med"},{"key":"1316_CR8","doi-asserted-by":"publisher","first-page":"e746","DOI":"10.1016\/j.ejrad.2012.01.032","volume":"81","author":"R Brenner","year":"2012","unstructured":"Brenner\u00a0R, Metens\u00a0T, Bali\u00a0M et\u00a0al (2012) Pancreatic neuroendocrine tumor: added value of fusion of T2-weighted imaging and high b\u2011value diffusion-weighted imaging for tumor detection. Eur J Radiol 81:e746\u2013e749","journal-title":"Eur J Radiol"},{"doi-asserted-by":"crossref","unstructured":"Calabr\u00f2 D, Argalia G, Ambrosini V (2020) Role of PET\/CT and Therapy Management of Pancreatic Neuroendocrine Tumors. Diagnostics 10:","key":"1316_CR9","DOI":"10.3390\/diagnostics10121059"},{"key":"1316_CR10","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/jmri.25756","volume":"47","author":"R Canellas","year":"2018","unstructured":"Canellas\u00a0R, Lo\u00a0G, Bhowmik\u00a0S et\u00a0al (2018) Pancreatic neuroendocrine tumor: Correlations between MRI features, tumor biology, and clinical outcome after surgery. J\u00a0Magn Reson Imaging 47:425\u2013432","journal-title":"J Magn Reson Imaging"},{"issue":"Suppl 2","key":"1316_CR11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1634\/theoncologist.13-S2-4","volume":"13","author":"H Choi","year":"2008","unstructured":"Choi\u00a0H (2008) Response evaluation of gastrointestinal stromal tumors. Oncologist 13(Suppl 2):4\u20137","journal-title":"Oncologist"},{"key":"1316_CR12","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1148\/radiol.13121628","volume":"268","author":"G D\u2019assignies","year":"2013","unstructured":"D\u2019assignies\u00a0G, Fina\u00a0P, Bruno\u00a0O et\u00a0al (2013) High sensitivity of diffusion-weighted MR imaging for the detection of liver metastases from neuroendocrine tumors: comparison with T2-weighted and dynamic gadolinium-enhanced MR imaging. Radiology 268:390\u2013399","journal-title":"Radiology"},{"key":"1316_CR13","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari\u00a0A, Shen\u00a0C, Halperin\u00a0D et\u00a0al (2017) Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States. JAMA Oncol 3:1335\u20131342","journal-title":"JAMA Oncol"},{"key":"1316_CR14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2214\/ajr.180.1.1800121","volume":"180","author":"C Dromain","year":"2003","unstructured":"Dromain\u00a0C, De Baere\u00a0T, Baudin\u00a0E et\u00a0al (2003) MR imaging of hepatic metastases caused by neuroendocrine tumors: comparing four techniques. Ajr Am J Roentgenol 180:121\u2013128","journal-title":"Ajr Am J Roentgenol"},{"key":"1316_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1200\/JCO.2005.01.013","volume":"23","author":"C Dromain","year":"2005","unstructured":"Dromain\u00a0C, De Baere\u00a0T, Lumbroso\u00a0J et\u00a0al (2005) Detection of liver metastases from endocrine tumors: a\u00a0prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging. J\u00a0Clin Oncol 23:70\u201378","journal-title":"J Clin Oncol"},{"key":"1316_CR16","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer\u00a0EA, Therasse\u00a0P, Bogaerts\u00a0J et\u00a0al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version\u00a01.1). Eur J Cancer 45:228\u2013247","journal-title":"Eur J Cancer"},{"doi-asserted-by":"crossref","unstructured":"El Ghannudi S, Ouvrard E, Mikail N et\u00a0al (2022) Cutting-Edge Imaging of Cardiac Metastases from Neuroendocrine Tumors: Lesson from a\u00a0Case Series. Diagnostics 12:","key":"1316_CR17","DOI":"10.3390\/diagnostics12051182"},{"key":"1316_CR18","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.2967\/jnumed.114.144543","volume":"55","author":"EC Etchebehere","year":"2014","unstructured":"Etchebehere\u00a0EC, De Oliveira Santos\u00a0A, Gumz\u00a0B et\u00a0al (2014) 68Ga-DOTATATE PET\/CT, 99mTc-HYNIC-octreotide SPECT\/CT, and whole-body MR imaging in detection of neuroendocrine tumors: a\u00a0prospective trial. J\u00a0Nucl Med 55:1598\u20131604","journal-title":"J Nucl Med"},{"key":"1316_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000443171","volume":"103","author":"M Falconi","year":"2016","unstructured":"Falconi\u00a0M, Eriksson\u00a0B, Kaltsas\u00a0G et\u00a0al (2016) ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors. Neuroendocrinology 103:153\u2013171","journal-title":"Neuroendocrinology"},{"key":"1316_CR20","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/MPA.0000000000000461","volume":"45","author":"A Farchione","year":"2016","unstructured":"Farchione\u00a0A, Rufini\u00a0V, Brizi\u00a0MG et\u00a0al (2016) Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography\/Computed Tomography. Pancreas 45:345\u2013354","journal-title":"Pancreas"},{"key":"1316_CR21","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1097\/SLA.0b013e3181fd37e8","volume":"252","author":"A Frilling","year":"2010","unstructured":"Frilling\u00a0A, Sotiropoulos\u00a0GC, Radtke\u00a0A et\u00a0al (2010) The impact of 68Ga-DOTATOC positron emission tomography\/computed tomography on the multimodal management of patients with neuroendocrine tumors. Ann Surg 252:850\u2013856","journal-title":"Ann Surg"},{"doi-asserted-by":"crossref","unstructured":"Granata V, Fusco R, De Muzio F et\u00a0al (2022) Contrast MR-Based Radiomics and Machine Learning Analysis to Assess Clinical Outcomes following Liver Resection in Colorectal Liver Metastases: A\u00a0Preliminary Study. Cancers 14:","key":"1316_CR22","DOI":"10.3390\/cancers14051110"},{"key":"1316_CR23","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s11547-021-01422-z","volume":"127","author":"F Gregucci","year":"2022","unstructured":"Gregucci\u00a0F, Fiorentino\u00a0A, Mazzola\u00a0R et\u00a0al (2022) Radiomic analysis to predict local response in locally advanced pancreatic cancer treated with stereotactic body radiation therapy. Radiol Med 127:100\u2013107","journal-title":"Radiol Med"},{"key":"1316_CR24","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.2967\/jnumed.110.075002","volume":"51","author":"AR Haug","year":"2010","unstructured":"Haug\u00a0AR, Auernhammer\u00a0CJ, Wangler\u00a0B et\u00a0al (2010) 68Ga-DOTATATE PET\/CT for the early prediction of response to somatostatin receptor-mediated radionuclide therapy in patients with well-differentiated neuroendocrine tumors. J\u00a0Nucl Med 51:1349\u20131356","journal-title":"J Nucl Med"},{"key":"1316_CR25","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.7150\/thno.19588","volume":"7","author":"E Hindi\u00e9","year":"2017","unstructured":"Hindi\u00e9\u00a0E (2017) The NETPET Score: Combining FDG and Somatostatin Receptor Imaging for Optimal Management of Patients with Metastatic Well-Differentiated Neuroendocrine Tumors. Theranostics 7:1159\u20131163","journal-title":"Theranostics"},{"key":"1316_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MPA.0000000000001454","volume":"49","author":"JR Howe","year":"2020","unstructured":"Howe\u00a0JR, Merchant\u00a0NB, Conrad\u00a0C et\u00a0al (2020) The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors. Pancreas 49:1\u201333","journal-title":"Pancreas"},{"doi-asserted-by":"crossref","unstructured":"Iacobellis F, Narese D, Berritto D et\u00a0al (2021) Large Bowel Ischemia\/Infarction: How to Recognize It and Make Differential Diagnosis? A\u00a0Review. Diagnostics 11:","key":"1316_CR27","DOI":"10.3390\/diagnostics11060998"},{"doi-asserted-by":"crossref","unstructured":"Ingenerf M, Kiesl S, Winkelmann M et\u00a0al (2022) Treatment Assessment of pNET and NELM after Everolimus by Quantitative MRI Parameters. Biomedicines 10:","key":"1316_CR28","DOI":"10.3390\/biomedicines10102618"},{"key":"1316_CR29","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1148\/rg.2020200025","volume":"40","author":"L Khanna","year":"2020","unstructured":"Khanna\u00a0L, Prasad\u00a0SR, Sunnapwar\u00a0A et\u00a0al (2020) Pancreatic Neuroendocrine Neoplasms: 2020 Update on Pathologic and Imaging Findings and Classification. Radiographics 40:1240\u20131262","journal-title":"Radiographics"},{"key":"1316_CR30","doi-asserted-by":"publisher","first-page":"437","DOI":"10.5858\/arpa.2015-0314-RA","volume":"140","author":"JY Kim","year":"2016","unstructured":"Kim\u00a0JY, Hong\u00a0SM (2016) Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts. Arch Pathol Lab Med 140:437\u2013448","journal-title":"Arch Pathol Lab Med"},{"key":"1316_CR31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1196\/annals.1294.002","volume":"1014","author":"G Kloppel","year":"2004","unstructured":"Kloppel\u00a0G, Perren\u00a0A, Heitz\u00a0PU (2004) The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann NY Acad Sci 1014:13\u201327","journal-title":"Ann NY Acad Sci"},{"key":"1316_CR32","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00330-013-3008-6","volume":"24","author":"GM Kukuk","year":"2014","unstructured":"Kukuk\u00a0GM, Murtz\u00a0P, Traber\u00a0F et\u00a0al (2014) Diffusion-weighted imaging with acquisition of three b\u2011values for response evaluation of neuroendocrine liver metastases undergoing selective internal radiotherapy. Eur Radiol 24:267\u2013276","journal-title":"Eur Radiol"},{"key":"1316_CR33","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s10140-002-0206-y","volume":"9","author":"F Lassandro","year":"2002","unstructured":"Lassandro\u00a0F, Scaglione\u00a0M, Rossi\u00a0G et\u00a0al (2002) Portomesenteric vein gas: diagnostic and prognostic value. Emerg Radiol 9:96\u201399","journal-title":"Emerg Radiol"},{"key":"1316_CR34","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1080\/14737140.2018.1496822","volume":"18","author":"L Lee","year":"2018","unstructured":"Lee\u00a0L, Ito\u00a0T, Jensen\u00a0RT (2018) Imaging of pancreatic neuroendocrine tumors: recent advances, current status, and controversies. Expert Rev Anticancer Ther 18:837\u2013860","journal-title":"Expert Rev Anticancer Ther"},{"key":"1316_CR35","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1148\/rg.306105523","volume":"30","author":"RB Lewis","year":"2010","unstructured":"Lewis\u00a0RB, Lattin\u00a0GE Jr., Paal\u00a0E (2010) Pancreatic endocrine tumors: radiologic-clinicopathologic correlation. Radiographics 30:1445\u20131464","journal-title":"Radiographics"},{"key":"1316_CR36","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1016\/j.ejrad.2011.10.028","volume":"81","author":"XZ Lin","year":"2012","unstructured":"Lin\u00a0XZ, Wu\u00a0ZY, Tao\u00a0R et\u00a0al (2012) Dual energy spectral CT imaging of insulinoma-Value in preoperative diagnosis compared with conventional multi-detector CT. Eur J Radiol 81:2487\u20132494","journal-title":"Eur J Radiol"},{"key":"1316_CR37","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.mric.2018.03.010","volume":"26","author":"GC Lo","year":"2018","unstructured":"Lo\u00a0GC, Kambadakone\u00a0A (2018) MR Imaging of Pancreatic Neuroendocrine Tumors. Magn Reson Imaging Clin N Am 26:391\u2013403","journal-title":"Magn Reson Imaging Clin N Am"},{"key":"1316_CR38","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1007\/s00330-016-4539-4","volume":"27","author":"E Lotfalizadeh","year":"2017","unstructured":"Lotfalizadeh\u00a0E, Ronot\u00a0M, Wagner\u00a0M et\u00a0al (2017) Prediction of pancreatic neuroendocrine tumour grade with MR imaging features: added value of diffusion-weighted imaging. Eur Radiol 27:1748\u20131759","journal-title":"Eur Radiol"},{"key":"1316_CR39","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3892\/ol_00000029","volume":"1","author":"T Masui","year":"2010","unstructured":"Masui\u00a0T, Doi\u00a0R, Ito\u00a0T et\u00a0al (2010) Diagnostic value of (18)F-fluorodeoxyglucose positron emission tomography for pancreatic neuroendocrine tumors with reference to the World Health Organization classification. Oncol Lett 1:155\u2013159","journal-title":"Oncol Lett"},{"key":"1316_CR40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2967\/jnumed.116.178095","volume":"58","author":"E Panagiotidis","year":"2017","unstructured":"Panagiotidis\u00a0E, Alshammari\u00a0A, Michopoulou\u00a0S et\u00a0al (2017) Comparison of the Impact of 68Ga-DOTATATE and 18F-FDG PET\/CT on Clinical Management in Patients with Neuroendocrine Tumors. J\u00a0Nucl Med 58:91\u201396","journal-title":"J Nucl Med"},{"key":"1316_CR41","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.carj.2013.02.001","volume":"64","author":"MN Patlas","year":"2013","unstructured":"Patlas\u00a0MN, Alabousi\u00a0A, Scaglione\u00a0M et\u00a0al (2013) Cross-sectional imaging of nontraumatic peritoneal and mesenteric emergencies. Can Assoc Radiol\u00a0J 64:148\u2013153","journal-title":"Can Assoc Radiol J"},{"key":"1316_CR42","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3390\/tomography9010018","volume":"9","author":"F Pellegrino","year":"2023","unstructured":"Pellegrino\u00a0F, Granata\u00a0V, Fusco\u00a0R et\u00a0al (2023) Diagnostic Management of Gastroenteropancreatic Neuroendocrine Neoplasms: Technique Optimization and Tips and Tricks for Radiologists. Tomography 9:217\u2013246","journal-title":"Tomography"},{"key":"1316_CR43","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1080\/02841850312331287869","volume":"44","author":"A Pinto","year":"2003","unstructured":"Pinto\u00a0A, Scaglione\u00a0M, Romano\u00a0L (2003) Perforation of a\u00a0gastrojejunal anastomosis due to acute pancreatitis revealed by helical computed tomography. Acta Radiol 44:572\u2013573","journal-title":"Acta Radiol"},{"key":"1316_CR44","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1245\/s10434-012-2305-7","volume":"19","author":"GA Poultsides","year":"2012","unstructured":"Poultsides\u00a0GA, Huang\u00a0LC, Chen\u00a0Y et\u00a0al (2012) Pancreatic neuroendocrine tumors: radiographic calcifications correlate with grade and metastasis. Ann Surg Oncol 19:2295\u20132303","journal-title":"Ann Surg Oncol"},{"key":"1316_CR45","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.2967\/jnumed.108.060236","volume":"50","author":"D Putzer","year":"2009","unstructured":"Putzer\u00a0D, Gabriel\u00a0M, Henninger\u00a0B et\u00a0al (2009) Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy. J\u00a0Nucl Med 50:1214\u20131221","journal-title":"J Nucl Med"},{"key":"1316_CR46","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11547-022-01449-w","volume":"127","author":"M Renzulli","year":"2022","unstructured":"Renzulli\u00a0M, Brandi\u00a0N, Argalia\u00a0G et\u00a0al (2022) Morphological, dynamic and functional characteristics of liver pseudolesions and benign lesions. Radiol Med 127:129\u2013144","journal-title":"Radiol Med"},{"key":"1316_CR47","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.beem.2007.01.003","volume":"21","author":"AG Rockall","year":"2007","unstructured":"Rockall\u00a0AG, Reznek\u00a0RH (2007) Imaging of neuroendocrine tumours (CT\/MR\/US). Best Pract Res Clin Endocrinol Metab 21:43\u201368","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1316_CR48","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1159\/000479293","volume":"106","author":"M Ronot","year":"2018","unstructured":"Ronot\u00a0M, Clift\u00a0AK, Baum\u00a0RP et\u00a0al (2018) Morphological and Functional Imaging for Detecting and Assessing the Resectability of Neuroendocrine Liver Metastases. Neuroendocrinology 106:74\u201388","journal-title":"Neuroendocrinology"},{"key":"1316_CR49","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.ejrad.2017.02.007","volume":"89","author":"M Ronot","year":"2017","unstructured":"Ronot\u00a0M, Cuccioli\u00a0F, Dioguardi Burgio\u00a0M et\u00a0al (2017) Neuroendocrine liver metastases: Vascular patterns on triple-phase MDCT are indicative of primary tumour location. Eur J Radiol 89:156\u2013162","journal-title":"Eur J Radiol"},{"key":"1316_CR50","doi-asserted-by":"publisher","first-page":"697","DOI":"10.2967\/jnumed.110.083741","volume":"52","author":"J Ruf","year":"2011","unstructured":"Ruf\u00a0J, Schiefer\u00a0J, Furth\u00a0C et\u00a0al (2011) 68Ga-DOTATOC PET\/CT of neuroendocrine tumors: spotlight on the CT phases of a\u00a0triple-phase protocol. J\u00a0Nucl Med 52:697\u2013704","journal-title":"J Nucl Med"},{"key":"1316_CR51","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1007\/s00261-012-9871-9","volume":"37","author":"V Rufini","year":"2012","unstructured":"Rufini\u00a0V, Baum\u00a0RP, Castaldi\u00a0P et\u00a0al (2012) Role of PET\/CT in the functional imaging of endocrine pancreatic tumors. Abdom Imaging 37:1004\u20131020","journal-title":"Abdom Imaging"},{"key":"1316_CR52","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s00261-020-02800-3","volume":"47","author":"M Scaglione","year":"2022","unstructured":"Scaglione\u00a0M, Galluzzo\u00a0M, Santucci\u00a0D et\u00a0al (2022) Small bowel obstruction and intestinal ischemia: emphasizing the role of MDCT in the management decision process. Abdom Radiol 47:1541\u20131555","journal-title":"Abdom Radiol"},{"key":"1316_CR53","first-page":"69","volume":"107","author":"M Scaglione","year":"2004","unstructured":"Scaglione\u00a0M, Grassi\u00a0R, Pinto\u00a0A et\u00a0al (2004) Positive predictive value and negative predictive value of spiral CT in the diagnosis of closed loop obstruction complicated by intestinal ischemia. Radiol Med 107:69\u201377","journal-title":"Radiol Med"},{"key":"1316_CR54","first-page":"1","volume":"6","author":"M Scaglione","year":"2005","unstructured":"Scaglione\u00a0M, Pinto\u00a0A, Romano\u00a0S et\u00a0al (2005) Using multidetector row computed tomography to diagnose and stage pancreatic carcinoma: the problems and the possibilities. JOP 6:1\u20135","journal-title":"JOP"},{"key":"1316_CR55","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s00259-013-2371-5","volume":"40","author":"C Schmid-Tannwald","year":"2013","unstructured":"Schmid-Tannwald\u00a0C, Schmid-Tannwald\u00a0CM, Morelli\u00a0JN et\u00a0al (2013) Comparison of abdominal MRI with diffusion-weighted imaging to 68Ga-DOTATATE PET\/CT in detection of neuroendocrine tumors of the pancreas. Eur J Nucl Med Mol Imaging 40:897\u2013907","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1316_CR56","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1007\/s00117-019-00586-0","volume":"59","author":"V Schwarze","year":"2019","unstructured":"Schwarze\u00a0V, Marschner\u00a0C, Grosu\u00a0S et\u00a0al (2019) Modern sonographic imaging of abdominal neuroendocrine tumors. Radiologe 59:1002\u20131009","journal-title":"Radiologe"},{"issue":"Suppl 1","key":"1316_CR57","doi-asserted-by":"publisher","first-page":"S142","DOI":"10.1016\/j.ijsu.2015.12.053","volume":"28","author":"M Scialpi","year":"2016","unstructured":"Scialpi\u00a0M, Reginelli\u00a0A, D\u2019andrea\u00a0A et\u00a0al (2016) Pancreatic tumors imaging: An update. Int J Surg 28(Suppl 1):S142\u2013S155","journal-title":"Int J Surg"},{"key":"1316_CR58","first-page":"69","volume":"60","author":"P Sharma","year":"2016","unstructured":"Sharma\u00a0P, Arora\u00a0S, Karunanithi\u00a0S et\u00a0al (2016) Somatostatin receptor based PET\/CT imaging with 68Ga-DOTA-Nal3-octreotide for localization of clinically and biochemically suspected insulinoma. Q\u00a0J Nucl Med Mol Imaging 60:69\u201376","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"1316_CR59","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/RLU.0000000000000257","volume":"39","author":"P Sharma","year":"2014","unstructured":"Sharma\u00a0P, Arora\u00a0S, Mukherjee\u00a0A et\u00a0al (2014) Predictive value of 68Ga-DOTANOC PET\/CT in patients with suspicion of neuroendocrine tumors: is its routine use justified? Clin Nucl Med 39:37\u201343","journal-title":"Clin Nucl Med"},{"key":"1316_CR60","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1007\/s00259-014-2850-3","volume":"41","author":"P Sharma","year":"2014","unstructured":"Sharma\u00a0P, Naswa\u00a0N, Kc\u00a0SS et\u00a0al (2014) Comparison of the prognostic values of 68Ga-DOTANOC PET\/CT and 18F-FDG PET\/CT in patients with well-differentiated neuroendocrine tumor. Eur J Nucl Med Mol Imaging 41:2194\u20132202","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1316_CR61","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/s41416-019-0558-7","volume":"121","author":"MP Solis-Hernandez","year":"2019","unstructured":"Solis-Hernandez\u00a0MP, Fernandez Del Valle\u00a0A, Carmona-Bayonas\u00a0A et\u00a0al (2019) Evaluating radiological response in pancreatic neuroendocrine tumours treated with sunitinib: comparison of Choi versus RECIST criteria (CRIPNET_ GETNE1504 study). Br J Cancer 121:537\u2013544","journal-title":"Br J Cancer"},{"key":"1316_CR62","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/j.ejrad.2011.09.012","volume":"81","author":"WH Sommer","year":"2012","unstructured":"Sommer\u00a0WH, Zech\u00a0CJ, Bamberg\u00a0F et\u00a0al (2012) Fluid–fluid level in hepatic metastases: A\u00a0characteristic sign of metastases of neuroendocrine origin. Eur J Radiol 81:2127\u20132132","journal-title":"Eur J Radiol"},{"key":"1316_CR63","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1159\/000471879","volume":"105","author":"A Sundin","year":"2017","unstructured":"Sundin\u00a0A, Arnold\u00a0R, Baudin\u00a0E et\u00a0al (2017) ENETS consensus guidelines for the standards of care in neuroendocrine tumors: radiological, nuclear medicine & hybrid imaging. Neuroendocrinology 105:212\u2013244","journal-title":"Neuroendocrinology"},{"key":"1316_CR64","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.soc.2015.11.007","volume":"25","author":"EP Tamm","year":"2016","unstructured":"Tamm\u00a0EP, Bhosale\u00a0P, Lee\u00a0JH et\u00a0al (2016) State-of-the-art Imaging of Pancreatic Neuroendocrine Tumors. Surg Oncol Clin N Am 25:375\u2013400","journal-title":"Surg Oncol Clin N Am"},{"key":"1316_CR65","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s12020-012-9631-1","volume":"42","author":"G Treglia","year":"2012","unstructured":"Treglia\u00a0G, Castaldi\u00a0P, Rindi\u00a0G et\u00a0al (2012) Diagnostic performance of Gallium-68 somatostatin receptor PET and PET\/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a\u00a0meta-analysis. Endocrine 42:80\u201387","journal-title":"Endocrine"},{"key":"1316_CR66","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/jmri.22541","volume":"33","author":"Y Wang","year":"2011","unstructured":"Wang\u00a0Y, Chen\u00a0ZE, Yaghmai\u00a0V et\u00a0al (2011) Diffusion-weighted MR imaging in pancreatic endocrine tumors correlated with histopathologic characteristics. J\u00a0Magn Reson Imaging 33:1071\u20131079","journal-title":"J Magn Reson Imaging"},{"key":"1316_CR67","doi-asserted-by":"publisher","first-page":"364","DOI":"10.2967\/jnumed.112.111724","volume":"54","author":"D Wild","year":"2013","unstructured":"Wild\u00a0D, Bomanji\u00a0JB, Benkert\u00a0P et\u00a0al (2013) Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET\/CT within patients with gastroenteropancreatic neuroendocrine tumors. J\u00a0Nucl Med 54:364\u2013372","journal-title":"J Nucl Med"}],"container-title":["Die Radiologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-024-01316-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00117-024-01316-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-024-01316-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T13:03:39Z","timestamp":1730207019000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00117-024-01316-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,24]]},"references-count":67,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["1316"],"URL":"https:\/\/doi.org\/10.1007\/s00117-024-01316-x","relation":{},"ISSN":["2731-7048","2731-7056"],"issn-type":[{"type":"print","value":"2731-7048"},{"type":"electronic","value":"2731-7056"}],"subject":[],"published":{"date-parts":[[2024,5,24]]},"assertion":[{"value":"24 April 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F.\u00a0Berger, M.\u00a0Ingenerf, C.J.\u00a0Auernhammer, C.\u00a0Cyran, R.\u00a0Ebner, M.\u00a0Zacherl, J.\u00a0Ricke und C.\u00a0Schmid-Tannwald geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}